Growth of Pharmaceutical Industry
	13:25 IST

LOK SABHA            There has been a considerable growth of pharmaceutical industry in the country during the last few years.  As per the information available with Pharmaceuticals Department through ORG-IMS, April, 2009 MAT value of Indian pharmaceutical market is Rs. 55,454 crores.  This includes retail pharmaceutical market at MRP, generic plus companies not tracked by ORG, hospitals and institutional sales (except Government procurement), direct doctor purchase, Pharmaceutical OTC products and diagnostics.  ORG-IMS has calculated detailed market at MRP from retail market at PTR (SSA Audit) and rest of all components are derived.            The average approximate MAT value for the last three years is as under:            April 2007 MAT             April 2008 MAT             April 2009 MAT          Rs. 43,904 crore           Rs. 50,410 crore           Rs. 55,454 crore                   This Department monitors production of selected bulk drugs only.  NPPA has reported that during the current year 2009-10, the price increase in respect of 122 cases of Scheduled drugs/formulations ranged between 0% to 25%.  Only in 3 cases, the price increase was between 25% to 50% mainly due to upward revision in the notified price of the bulk drug.  The details of all these cases are available on the NPPA’s website www. Nppaindia.nic.in.            As a part of price monitoring activity, NPPA regularly examines the movement in prices of non-scheduled formulations.  The monthly reports of ORG IMS and the information furnished by individual manufacturers are utilized for the purpose of monitoring prices of non-scheduled formulations.  Wherever a price increase beyond 10% per annum (It was 20% before 1.4.2007) is noticed, the manufacturer is asked to bring down the price voluntarily failing which, subject to prescribed conditions, action is initiated under paragraph 10(b) of the DPCO, 1995 for fixing the price of the formulation in public interest.  Based on monitoring of prices of non-scheduled formulations, NPPA has fixed prices in case of 27 formulation packs under this paragraph and companies have reduced price voluntarily in case of 64 formulation packs.  Thus in all, prices of 91 packs of non-scheduled drugs have got reduced as a result of the intervention of NPPA.  This is an ongoing process.            This was informed by the Minister of State for Chemicals and Fertilizers Shri Srikant Kumar Jena in a written reply in the Lok Sabha today. ..... PKM/SB